Member Info for Yozzer73

It’s when the directors can’t do any dealings due to being privy to insider information. i.e. end of year results pending as is the case for BRH. Normal to get updates on things too in EoY results, which make it even more sensitive to not divulge things prior to the RNS being issued. Hence since 29th September RNS only new acquisitions have been reported on and nothing else

Bless there’s a fan club started up. Guess I’m not invited.

Good call donotpanic, indeed it was a blue day…..just about. But in the wise words of Halma, ‘it was a 50/50 call :)

Helms you remind me very much of Jasorge. He continually adding nothing to the conversation but said a lot. Sometimes it’s best to say nothing if you’ve got nothing constructive to add. Odd chats you add as a supposed investor!?

Definitely a good price to get in at. November is only so long and some juicy bits of news incoming:

- sepsis & cancer
- Covid progress on manufacturing/selling off
- end of years

GL all

Exactly Olwi. I think the trickle selling is mainly the II’s selling from the placing. They’re still up a nice 66% even at these lows, probably finding it hard to sell circa 5 million shares imao.

As mentioned already by many on the BB, October was never going to have any news due to having it all on the 29th September and being a closed period. Except for the acquisition investments of course.

Some people are just to lazy to think or ask the questions to the right people. Ignorance pays no dividends to the ignorant who sell up.

GL all LTHs

Yesterday I spoke to Viv. He confirmed in not so many words:

Note: He was unable to elaborate to deep at present, as BRH are in a closed period due to the preparing of interim statements and end of year accounts, to be released in November.

Covid 19 - Progressing well and still on schedule.
- Placing was all taken up and funds are all
purely for the the progression of the Covid
Fast Test

Autins - was deemed as a substantial investment from available balance sheet funds. But was unable to confirm it’s importance in whether it was a strategic (to do with Covid manufacturing) or just another independent portfolio investment due to being in the closed period.

Velocity - was a minor investment hence the lack of RNS, but like Autins it was from available balance sheet funds.

All in all a positive chat. Lots of news and good stuff coming our way. Just a crap closed period stemming the flow of information. Just a bit of patience required it’s nearly November

Could be the same person buying and selling? transferring shares over to an ISA or to another family member who has all their capital gains allowance still for the year…… as mentioned block buys seemed fairly even.

Your right the BoD have several questions to be answered regarding the recent acquisitions.

Andy have you asked Viv/Trev the questions? Pointless spouting issues if you’re not willing to ask the questions to those with the actual answers.

Just a point of note, remember BRH was flush to the tune of £2m before any fund raising, after the RMS sale was done.

LTH14 look at the price paid on the 2m shares 24.75p. That’s nothing to do with the Placing or OO

Just done some quick maths. So 1,500,615 was bought up. This is made up of 415,615 +85,000+ 85,000+830,000 (can’t account for 85,000 difference but could be LSE site details are missing a transaction - nothing new)

Conveniently at the same time as the two biggest dealings, there was one for 831,000 and again 416,177. Is this Trev feathering his nest again?! Hmmm!!

Remember gents that we had £2m in the bank from the RMS sale. So either way it’s an educated purchase by the BoD, be it for manufacturing or further investment and not necessarily using any of the placing funds.

If you look at the share purchases on Volocity recently there’s more to it. More than 1.5mil share have been bought in recent times. For a firm that doesn’t seem to do much share dealings on a daily/weekly basis!? Is TB having a side dabble like with Chamberlain?? Questions questions!!

Hey Casper hope you’re all well? Have you opted to buy back in?

More chance of June having 31 days in it, than GDR having sales. Wouldn’t you agree Dave?! :) lmao

ZEPHI your not even elaborating in your text or title what you’re actually going on about. So why bother this BB with your blindness. Do some proper research and don’t cherry pick fragments of actual fact and add it to your aimless assumptions.

Jog on time waster!!

X30 - I would say from discussions with it saying engagement, and they’ve been engaged a fair few months now. Hence the placing happening to either force the hand of the manufacturer to give a good offer for the Covid test, or as mentioned by TB, he’ll take it to market independently using the placing monies.

Guys just a reminder of an older post I did. There is a webinar by VUMC on the 21 Sep for the AD

Julius Clinical and Amsterdam UMC are proud to present the webinar: Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials.
During this live webinar, Charlotte Teunissen, Professor in Neurochemistry at Amsterdam UMC will touch upon: o Patient selection o Patient stratification o Outcome measures
Theme: Biomarkers in Alzheimer's disease
Target audience: Pharmaceutical and biotech companies
Main language: English

You don’t do this if the product is inconclusive!? DYOR :)
The above was curtesy of Castle, who took the time to follow up on Starknights research into Amsterdam UMC

Hope we sell tomorrow and donotpanic has seriously missed the boat. I’d laugh my arse off. A seasoned ramper? and after 13k posts, still doesn’t know their arse from their elbow!? Lmao

X30 think you need to do some research with RNSs before blindly posting for the first time on this BB. A lot will tell you the same DYOR, don’t expect others to do it for you

Speed to market is essential now, fortunately with a capitalist like TB at the helm and invested for the big win. Getting to market has to be coming soon.

Cheers for the weblink Castle. Found this in the future events regarding AD. Cutting edge developments it states. You don’t call it that unless it’s going places imao

Webinar: Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
Congress & symposium
Start date:
21 september 2021
Julius Clinical and Amsterdam UMC are proud to present the webinar: Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials.